Eikon Therapeutics Inc (EIKN) Price Prediction & ForecastEIKNEikon Therapeutics Inc

Alphio's EIKN stock price prediction model matches the current Eikon Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.85 (-0.23%). The 1-week path is $10.89 (+0.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Eikon Therapeutics is currently trading at $10.98, which is significantly below the analyst price targets of $29 to $34. However, the company has a negative earnings per share (EPS) of -1.63 and a year-to-date change of -39%, indicating substantial financial challenges. The RSI is at 45.55, suggesting it is neither overbought nor oversold, which is a neutral signal. While there are positive catalysts such as advancements in clinical trials for EIK1001, the overall financial performance and significant losses pose risks. Given the mixed analyst ratings and the current price being well below targets, it may be prudent to hold rather than buy at this time.

Eikon Therapeutics Inc (EIKN) last closed at $10.88, gaining +4.02%. These facts feed the 1-day and 1-week EIKN price prediction above.